Cite
Yassin MA, Nashwan AJ, Soliman AT, et al. Cytomegalovirus-induced Hemorrhagic Colitis in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront Therapy. Clin Med Insights Case Rep. 2015;8:77-81doi: 10.4137/CCRep.S25327.
Yassin, M. A., Nashwan, A. J., Soliman, A. T., Yousif, A., Moustafa, A., AlBattah, A., Mohamed, S. F., Mudawi, D. S., Elkourashy, S., Asaari, D. R., Gutierrez, H. L., Almusharaf, M., Hussein, R. M., Moustafa, A. H., Derhoubi, H. E., Boukhris, S., Kohla, S., & AlDewik, N. (2015). Cytomegalovirus-induced Hemorrhagic Colitis in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront Therapy. Clinical medicine insights. Case reports, 877-81. https://doi.org/10.4137/CCRep.S25327
Yassin, Mohamed A, et al. "Cytomegalovirus-induced Hemorrhagic Colitis in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront Therapy." Clinical medicine insights. Case reports vol. 8 (2015): 77-81. doi: https://doi.org/10.4137/CCRep.S25327
Yassin MA, Nashwan AJ, Soliman AT, Yousif A, Moustafa A, AlBattah A, Mohamed SF, Mudawi DS, Elkourashy S, Asaari DR, Gutierrez HL, Almusharaf M, Hussein RM, Moustafa AH, Derhoubi HE, Boukhris S, Kohla S, AlDewik N. Cytomegalovirus-induced Hemorrhagic Colitis in a Patient with Chronic Myeloid Leukemia (Chronic Phase) on Dasatinib as an Upfront Therapy. Clin Med Insights Case Rep. 2015 Aug 26;8:77-81. doi: 10.4137/CCRep.S25327. eCollection 2015. PMID: 26379451; PMCID: PMC4554353.
Copy
Download .nbib